FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER

Described herein are methods of treating high-risk non-muscle invasive bladder cancer (HR-NMIBC) comprising administering a fibroblast growth factor receptor (FGFR) inhibitor. Also described are methods of treating intermediate risk non-muscle invasive bladder cancer (IR-NMIBC) comprising administer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MONGA, MANISH, BAIG, MAHADI ALI
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Described herein are methods of treating high-risk non-muscle invasive bladder cancer (HR-NMIBC) comprising administering a fibroblast growth factor receptor (FGFR) inhibitor. Also described are methods of treating intermediate risk non-muscle invasive bladder cancer (IR-NMIBC) comprising administering an FGFR inhibitor. L'invention concerne des procédés de traitement du cancer de la vessie invasif non musculaire à haut risque (HR-NMIBC) comprenant l'administration d'un inhibiteur du récepteur du facteur de croissance des fibroblastes (FGFR). L'invention concerne également des procédés de traitement du cancer de la vessie invasif non musculaire à risque intermédiaire (IR-NMIBC) comprenant l'administration d'un inhibiteur de FGFR.